OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Home » Week of 2/19/24-2/23/24
The Viridian Value Tracker is the most comprehensive valuation product in the industry.
Valuations in the Consumption Device subsector are surprisingly strong, given the well-known issues at Greenlane (GNLN: Nasdaq) and Item 9 Labs (INLB: OTC). The median market to book for the eight-member group is 1.13x, and the median EV/Annualized Revenues is a surprising 1.66x. The averages are skewed much higher by Turning Point (TPB: NYSE), with 3x mkt to book and 1.7x EV/ annualized revenues, and Ispire (ISPR: Nasdaq) at 19x Mkt/book and 3.2x EV/annualized revenues. This skewing of averages is one reason Viridian uses the median and quartiles in our valuation and credit norms analysis.
Valuations in the Consumption Device subsector are surprisingly strong, given the well-known issues at Greenlane (GNLN: Nasdaq) and Item 9 Labs (INLB: OTC). The median market to book for the eight-member group is 1.13x, and the median EV/Annualized Revenues is a surprising 1.66x. The averages are skewed much higher by Turning Point (TPB: NYSE), with 3x mkt to book and 1.7x EV/ annualized revenues, and Ispire (ISPR: Nasdaq) at 19x Mkt/book and 3.2x EV/annualized revenues. This skewing of averages is one reason Viridian uses the median and quartiles in our valuation and credit norms analysis.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.
Copyright Viridian Capital Advisors © 2022